APGE: Apogee Therapeutics, Inc. Stock

by  •  • Comments Off on APGE: Apogee Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,418.30
Enterprise Value ($M) 1,276.51
Book Value ($M) 716.79
Book Value / Share 16.07
Price / Book 1.98
NCAV ($M) 492.56
NCAV / Share 11.04
Price / NCAV 2.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.23

Liquidity (mrq)
Quick Ratio 18.55
Current Ratio 18.55

Balance Sheet (mrq) ($M)
Current Assets 529.71
Assets 753.95
Liabilities 37.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -216.87
Net Income -182.15

Cash Flow Statement (mra) ($M)
Cash From Operations -171.17
Cash from Investing -300.46
Cash from Financing 495.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Rtw Investments, Lp 6.00
11-14 13G/A Ra Capital Management, L.p. 3.40 -0.81
11-14 13G/A Deep Track Capital, LP 2.22 -56.96
11-14 13G Driehaus Capital Management Llc 5.63
11-12 13G/A Fmr Llc 16.67 49.49
11-08 13G BlackRock, Inc. 6.60 0.00
11-04 13G/A Access Industries Management, Llc 4.87 12.88
10-04 13G Wellington Management Group Llp 10.70
2024-04-01 13D/A Fairmount Funds Management LLC 9.99 -11.85

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-14 125,441 449,019 27.94
2025-04-11 166,388 653,027 25.48
2025-04-10 302,946 855,281 35.42
2025-04-09 317,954 1,475,553 21.55

(click for more detail)

Similar Companies
AFMD – Affimed N.V. ALT – Altimmune, Inc.
ANIP – ANI Pharmaceuticals, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io